RecruitingNANCT07561255

Real-world Quality Management Study With Axia to Evaluate the Measures of the DigiG (RAEMD Study)

Sponsor: Wuerzburg University Hospital

Trial Details

Condition	Spondylitis, Ankylosing, Mobile Phone Use
Intervention	Test-phase with immediate access; Standard procedure
Phase	NA
Status	Recruiting
Participants	200
Est. Completion	31 Dec 2026
Last Updated	1 May 2026

Primary Outcome

Percentage of participants with successful Axia app activation within 12 weeks, assessed by successful redemption of the activation code

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: * Willingness to use Axia. * Axia indication area. * Willingness to activate via onboarding brochure. Exclusion Criteria: * Absence of the inclusion criteria

Trial Sites

Countries

Germany

View Registry Entry

Related Analysis

German Digital Health Study Tests App Activation Strategies for Ankylosing Spondylitis Management — Implications for Australian Digital Therapeutics

German researchers are testing two onboarding strategies for a digital therapeutic app in ankylosing spondylitis patients. The RAEMD study compares standard insurance activation versus immediate trial access, with findings relevant for Australian digital health implementation.

Read full article →

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service